Hypothesis

Rapamycin extends lifespan chiefly by lowering the rate of new oxidative DNA damage through enhanced mitophagy and reduced metabolic flux, while simultaneously dampening the transcription of base‑excision repair (BER) genes via the mTORC1‑S6K1‑p300 axis. The net effect is a shift from damage removal to damage prevention. In contexts where the existing lesion load is high—such as aged neurons or DNA‑repair‑deficient backgrounds—this shift becomes detrimental, limiting or abolishing the longevity benefit.

Mechanistic Rationale

1. Damage prevention arm – mTORC1 inhibition activates ULK1‑dependent autophagy and TFEB‑driven lysosomal biogenesis, leading to selective removal of damaged mitochondria (mitophagy). Lower mitochondrial ROS production decreases the formation of 8‑oxoguanine (8‑oxoG) lesions, as shown by reduced γ‑H2AX and 8‑oxoG immunoreactivity in rapamycin‑treated immune cells [5].
2. Repair suppression arm – Active mTORC1 phosphorylates S6K1, which in turn phosphorylates the histone acetyltransferase p300/CBP, promoting acetylation of H3K27 at promoters of BER genes (OGG1, APE1, POLβ). Inhibition of mTORC1 reduces S6K1 activity, decreasing p300‑mediated acetylation, resulting in a more compact chromatin state and lowered transcription of these repair enzymes. This aligns with the observation that rapamycin does not upregulate OGG1 or APE1 despite lowering new damage [1] and active

Hypothesis

Senescent immune cells, particularly GZMK+ CD8+ T cells and macrophages, release extracellular vesicles (EVs) enriched in SASP factors and mitochondrial DNA that infiltrate stem cell niches. These EVs induce oxidative stress and telomere attrition in niche stromal cells, which precedes and drives stem cell senescence. Blocking EV biogenesis in senescent immune cells will preserve niche telomere length, maintain regenerative capacity, and extend healthspan independent of other interventions.

Mechanistic Rationale

1. EV-mediated SASP delivery – Senescent immune cells secrete EVs containing IL‑6, IL‑1β, GZMK, and oxidized mtDNA (3, 4). Unlike soluble SASP, EVs protect cargo from degradation and enable targeted delivery to nearby stromal cells.
2. Mitochondrial damage transfer – EV‑carried mtDNA triggers cGAS‑STING activation in niche fibroblasts, leading to ROS production and telomere shortening (5). This links immune senescence directly to the observed earlier telomere attrition in niche cells versus stem cells (2).
3. Feedback amplification – Telomere‑damaged niche cells secrete their own SASP, further recruiting and senescing immune cells, creating a self‑propagating loop that accelerates inflammaging via NF‑κB ([6](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.

Hypothesis

Chronic pain triggers microglial NLRP3 inflammasome activation, which consumes NAD+ through PARP1 and CD38 activity, lowering SIRT1-mediated deacetylation of histone and metabolic regulators. This NAD+ decline drives DNA methylation shifts captured by epigenetic clocks (especially DNAmGrimAge) and produces a feed‑forward loop that heightens pain sensitivity. Restoring NAD+ should break the loop, reducing both pain hypersensitivity and epigenetic age acceleration.

Mechanistic Reasoning

• Microglial priming: Persistent nociceptive signaling activates microglia via TLR4 and P2X7 receptors, leading to NLRP3 inflammasome assembly (6).
• NAD+ consumption: Activated NLRP3 stimulates PARP1 (DNA damage response) and upregulates CD38, both major NAD+ hydrolyzing enzymes (1).
• SIRT1 suppression: Lower NAD+ reduces SIRT1 deacetylase activity, increasing acetylation of NF‑κB and histones, promoting a pro‑inflammatory transcriptome and altering DNA methyltransferase recruitment (3).
• Epigenetic outcome: SIRT1 loss correlates with GrimAge acceleration; NAD+ repletion rescues SIRT1 function and normalizes methylation patterns in aging models (4).
• Pain phenotype: Heightened microglial IL‑1β release sensitizes peripheral nociceptors, lowering heat and pressure thresholds; NAD+ boost attenuates cytokine release and restores nociceptive balance

Hypothesis

Sustained ASK1‑MKK7‑JNK signaling, driven by mitochondrial ROS that persists beyond the first hour of stress, rewires AP‑1 dimer composition toward JunD/FosL1 heterodimers, which then preferentially bind and sustain transcription of a core SASP subset (IL‑6, IL‑8, MMP‑3) in senescent cells.

Mechanistic Rationale

1. Kinetic switch – Rapid JNK activation via GCKR/TRAF2 phosphorylates c‑Jun (Ser63/73) favoring c‑Jun/c‑Fos dimers that drive immediate‑early genes.
2. ROS‑dependent ASK1 – Mitochondrial ROS that accumulates over 20 min–1 h sustains ASK1 activity, leading to prolonged MKK7‑JNK signaling.
3. Dimer bias – Chronic JNK activity favors phosphorylation of JunD and FosL1 (which have lower turnover and distinct docking sites) over c‑Jun, shifting AP‑1 heterogeneity.
4. SASP lock‑in – JunD/FosL1‑AP‑1 binds composite sites with NF‑κB and C/EBPβ at SASP promoters, creating a feed‑forward loop that maintains SASP despite attenuation of upstream stress signals.
5. Mitochondrial dependence – Eliminating mitochondria (e.g., via Parkin overexpression) or scavenging ROS with MitoQ should prevent the JunD/FosL1 shift and attenuate SASP, even if acute JNK spikes occur.

Testable Predictions

• Prediction 1: In cells undergoing senescence (e.g., IR‑induced or oncogenic RAS), phospho‑JNK levels will show a biphasic pattern: an early peak (<15 min) followed by a sustained plateau (>2 h) that correlates with mitochondrial ROS measured by MitoSOX.
• Prediction 2: ChIP‑seq for JunD and FosL1 will reveal enriched binding at SASP gene promoters

Hypothesis

Repeated hormetic stressors (e.g., intermittent hypoxia, exercise, polyphenols) improve arterial stiffness only while they are present by acutely increasing endothelial nitric oxide (NO) bioavailability via eNOS activation and the Nrf2‑antioxidant axis. They do not reverse the structural determinants of stiffness—elastin fragmentation, collagen cross‑linking, and advanced glycation end‑product (AGE) accumulation. Consequently, after cessation of the hormetic stimulus, arterial stiffness will rebound to or exceed pre‑intervention levels, and the magnitude of rebound will correlate with the burden of irreversible elastin damage and AGEs.

Mechanistic Rationale

Hormetic cues raise intracellular ROS to a level that activates redox‑sensitive kinases (AMPK, AKT) and transcription factors (Nrf2, HIF‑1α), leading to transient eNOS phosphorylation and increased NO output [1][2]. This boosts NO‑mediated vasodilation and acutely reduces vascular tone, which is captured by lower pulse wave velocity (PWV). However, the same ROS burst does not sufficiently activate matrix metalloproteinases (MMPs) or inhibit lysyl oxidase (LOX) to degrade cross‑linked elastin or collagen, nor does it stimulate elastin tropoelastin synthesis. Moreover, chronic NO deficiency promotes eNOS uncoupling, perpetuating oxidative stress that drives AGE formation via glyoxal pathways [5]. Hormesis therefore masks functional stiffness by

Hypothesis

Senescent mesenchymal cells in aged male mouse livers upregulate Wif1 and Smoc1, enzymes that remodel extracellular matrix and modulate Wnt signaling [1]. We propose that this matrix remodeling changes the binding affinity of heparan sulfate proteoglycans for chemokines such as CXCL10, thereby altering systemic chemokine gradients that guide immune cell trafficking. In aged brains, CXCL10‑dependent CD8⁺ T cell accumulation around demyelinated axons is observed [2], but the source of the chemokine gradient is unclear. We hypothesize that soluble factors released from liver senescent niches travel through the circulation, reprogramming the extracellular matrix of cerebral vasculature and white matter, which stabilizes CXCL10 at perivascular sites and sustains T‑cell recruitment.

Testable predictions

1. Reducing Wif1/Smoc1 activity in liver senescent mesenchymal cells will normalize hepatic matrix composition and decrease circulating matrix‑modulating activity.
2. This normalization will flatten CXCL10 gradients in aged brain white matter, leading to fewer infiltrating CD8⁺ T cells.
3. Conversely, overexpression of Wif1/Smoc1 in young liver mesenchymal cells will induce an aged‑like CXCL10 gradient and increase brain T‑cell infiltration.

Experimental approach

Cell isolation – Senescent mesenchymal cells will be harvested from livers of 24‑mo

Hypothesis

NLRP3 activation in aged macrophages drives mitochondrial DNA (mtDNA) release into the cytosol, which then engages the cGAS‑STING pathway to boost IL‑6 trans‑signaling via soluble IL‑6R. This amplified IL-6 signal sustains STAT3‑mediated transcription of a senescence‑associated secretory phenotype (SASP), creating a feed‑forward loop that locks cells into immunosenescence. Blocking mtDNA efflux or STING signaling should break the loop and restore youthful cytokine responsiveness even when NLRP3 remains active.

Mechanistic Rationale

• NLRP3 inflammasome assembly is triggered by mitochondrial dysfunction, oxidized mtDNA and ROS, leading to caspase‑1 activation and IL-1β maturation [1].
• Caspase-1 also cleaves gasdermin D, forming pores that permit mtDNA efflux into the cytosol [1].
• Cytosolic mtDNA activates cGAS, producing cGAMP that stimulates STING, which induces IRF3‑driven IFN‑β and NF‑κB‑dependent transcription of IL-6 and IL-6R [2].
• IL-6 released can act in trans‑signaling mode when bound to soluble IL-6R, activating STAT3 in neighboring cells and reinforcing SASP gene expression [2].
• STAT3 signaling promotes p16^INK4a^ and p21^Cip1^ expression, driving a stable senescent state that impairs TNF-α, IL-1β and IL-12 production upon LPS challenge [2].
• Genetic Nlrp3 knockout prevents immune senescence‑driven vascular aging in diabetic models, indicating that NLRP3 activity precedes tissue pathology [3].

Testable Predictions

1. In macrophages from old donors, inhibiting cGAS or STING will reduce phospho-STAT3 levels and SASP cytokines without

Hypothesis

Core claim: During natural sleep, neuronal AMPK undergoes brief, high‑amplitude pulses that selectively activate autophagy of stalled ribosomal complexes via phosphorylation of the autophagy receptor p62/SQSTM1 at Ser403. This “ribophagy” window prevents the buildup of translation‑derived proteotoxic species that would otherwise impair synaptic plasticity. In wakefulness, AMPK activity remains low or tonic, failing to trigger this selective pathway; chronic, unregulated AMPK activation (as seen in aging) drives non‑selective autophagy and synaptic loss.

Mechanistic rationale

1. Metabolic gate: Sleep reduces cerebral glucose utilization and raises the AMP:ATP ratio, providing the biochemical trigger for AMPK Thr172 phosphorylation.
2. Spatial specificity: Hippocampal neurons express predominantly AMPKα2, which couples to the scaffolding protein AXIN 1, facilitating rapid diffusion to perisynaptic ribosomes when activated.
3. Selective autophagy trigger: Phosphorylated p62/SQSTM1 acquires a high affinity for ubiquitin‑tagged 40S subunits and the translation‑stall marker eIF2α‑P, nucleating autophagosome formation around these cargos.
4. Temporal restriction: The pulse lasts ~5‑10 min per NREM cycle, sufficient to clear a defined ribosomal load without depleting essential synaptic proteins.
5. Pathological shift: In aged or sleep‑deprived brains, AMPK activation becomes prolonged, overwhelming the selective mechanism and engaging bulk autophagy that indiscriminately degrades postsynaptic density proteins (e.g., PSD‑95, GluA1), mirrori

Hypothesis

Aged cardiac progenitor cells (CPCs) accumulate mitochondrial DNA damage that activates the cytosolic DNA sensing pathway cGAS‑STING, driving a chronic type‑I interferon response that amplifies the senescence‑associated secretory phenotype (SASP) and locks cells into a glycolytic, low‑ATP state. We hypothesize that pharmacological inhibition of STING will simultaneously reduce SASP secretion, restore mitochondrial oxidative phosphorylation, and re‑enable differentiation of aged CPCs into cardiomyocyte lineages.

Mechanistic rationale

1. Mitochondrial DNA damage → cGAS‑STING activation

   • mtDNA lesions increase in aged CPCs (2) and can escape to the cytosol, where they bind cGAS, producing 2′‑3′‑cGAMP and stimulating STING (4).
   • STING signaling drives IRF3‑dependent IFN‑β production, which has been shown to reinforce p16^INK4a^ expression and SASP in other senescent cell types.

2. STING‑driven IFN signaling amplifies SASP

   • Chronic IFN‑β signaling upregulates secreted IL‑6, IL‑8, and MCP‑1, creating a paracrine loop that induces senescence in neighboring CPCs (3).
   • This loop explains the observed ~60% SA‑β‑gal positivity in aged CPCs versus ~35% in young cells (1).

3. Metabolic consequence

   • IFN‑β signaling suppresses PGC‑1α transcription, reducing mitochondrial biogenesis and forcing reliance on glycolysis, which limits ATP pr

Hypothesis

Rapamycin‑mediated mTORC1 inhibition creates a scarcity‑mimetic epigenetic program that extends lifespan only when the external environment remains predictably low‑stress; under fluctuating or novel stressors this program reduces physiological flexibility and shortens survival.

Mechanistic Basis

mTORC1 suppression lowers S6K activity and 4E‑BP phosphorylation, decreasing global translation and favoring transcription of ATF4‑driven stress genes rapamycin induces autophagy and ATF4-mediated stress responses, mimicking hormesis rather than repairing damage. This shift conserves resources but also remodels chromatin via reduced acetyl‑CoA production, promoting histone deacetylation at promoters of growth‑related genes. Concurrently, lowered HIF‑1α translation diminishes hypoxia‑inducible signaling, attenuating the ability to mount rapid glycolytic bursts during acute oxygen deprivation. The net effect is a cellular state resembling dauer or diapause: high maintenance, low proliferation, and a rigid epigenome that resists re‑programming when conditions change.

Testable Predictions

• Organisms treated with rapamycin will show increased lifespan under constant low‑nutrient, low‑temperature conditions but decreased lifespan when exposed to intermittent high‑nutrient pulses or acute heat shock compared with untreated controls.
• Rapamycin‑treated animals will exhibit reduced inducible HSP70 expression and slower recovery from protein‑aggregation stress despite higher basal autophagy levels.
• Chr

Hypothesis

In aged, normoglycemic tissues, elevated hexosamine biosynthetic pathway (HBP) flux drives O-GlcNAcylation of the transcription factor TFEB, which blocks its nuclear import and lysosomal gene expression, thereby suppressing autophagosome‑lysosome fusion and flux. This mechanism explains autophagy stall as an active metabolic suppression, not just passive wear‑and‑tear.

Mechanistic rationale

• HBP flux rises with age due to increased glutamine uptake and altered glycolytic shunting, producing more UDP‑GlNAc even when blood glucose is normal.
• O-GlcNAc transferase (OGT) modifies TFEB on serine/threonine residues that overlap with phosphorylation sites required for its interaction with importins and 14‑3‑3 release.
• O-GlcNAcylated TFEB exhibits higher affinity for cytoplasmic 14‑3‑3 proteins, sequestering it away from the nucleus, reducing transcription of lysosomal genes (e.g., LAMP1, CATD) and autophagosome‑lysosome tethering factors.
• Reduced lysosomal biogenesis limits the availability of functional lysosomes, causing autophagosomes to accumulate despite intact upstream initiation—mirroring the SNAP29‑dependent block described in diabetic cardiomyocytes[1].
• The effect is nutrient‑sensitive and evolutionarily conserved, as O-GlcNAc cycling modulates autophagy in C. elegans independent of hyperglycemia[2], and OGT loss alleviates proteotoxicity via enhanced autophagy[3].
• Concurrently, lowered O-GlcNAc diminishes mTORC1 activity[4], creating a feedback loop where O-GlcNAc both directly blocks TFEB and indirectly sustains mTORC1‑mediated autophagy inhi

Hypothesis

Age‑related decline in mitochondrial quality control increases reactive oxygen species (ROS) production specifically in colonic stem cells. Elevated ROS reduces SIRT6 deacetylase activity, which in turn diminishes deacetylation of H3K9 and H3K56 at mismatch repair (MMR) gene promoters. This epigenetic silencing lowers MMR protein levels, creating a permissive environment for DNA methylation errors that spread clonally from the crypt base, establishing a field cancerization phenotype.

Mechanistic Model

1. Mitochondrial stress in aging stem cells – Aging impairs mitophagy, causing accumulation of damaged mitochondria and leakage of electron‑transport‑chain electrons, raising superoxide levels in the crypt base {1}.
2. ROS‑mediated SIRT6 inhibition – ROS oxidizes cysteine residues in SIRT6’s catalytic domain, reducing its NAD‑dependent deacetylase activity. SIRT6 normally removes acetyl groups from histone H3K9ac and H3K56ac at promoters of MLH1, MSH2, and MSH6, maintaining an open chromatin state conducive to transcription. Loss of SIRT6 activity leads to hyperacetylation, recruitment of HDAC‑containing repressive complexes, and promoter compaction.
3. Transcriptional repression of MMR genes – Compacted chromatin reduces RNA polymerase II occupancy, decreasing MMR transcript and protein levels. Experimental data show that SIRT6 knockout in mouse intestinal epithelium mimics age‑related MMR decline {2}.
4. **Epigenetic drift and f

Hypothesis

Age‑related methylation of nucleosome‑positioning genes increases chromatin compaction, protecting specific DNA fragments from enzymatic trimming and thereby shifting cfDNA size distributions toward longer fragments.

Mechanistic Basis

Recent work identified ~2,000 age‑differentially methylated CpG sites enriched in nucleosome structure genes [1]. Methylation at CpG islands within promoters of histone chaperones (e.g., NASP, CAF1) and linker histone variants can reduce their expression, leading to tighter nucleosome packing and reduced accessibility of DNA to apoptosis‑associated nucleases. Tighter nucleosomes generate longer protected fragments during apoptosis because the nuclease cuts less frequently between closely spaced nucleosomes. Consequently, plasma from older individuals shows a relative increase of 300‑400 bp cfDNA fragments alongside the canonical ~166 bp peak [2]. This provides a direct mechanistic link between the methylation signature used in cfDNA clocks and the fragmentomics shift observed with age.

Testable Predictions

1. Plasma from individuals with accelerated epigenetic age (e.g., AA>5 years) will have a higher proportion of long cfDNA fragments (>300 bp) after adjusting for total cfDNA concentration.
2. In vitro knockdown of a methylated nucleosome gene (e.g., NASP) in cultured senescent fibroblasts will decrease cfDNA fragment length in the supernatant, shifting the profile toward the mononucleosomal peak.
3. Pharmacological inhibition of DNA methyltransferases (5‑aza‑2′‑deoxycytidine) in aged mice will reduce methylation at nucl

Hypothesis

Senescent cells do not merely secrete soluble factors; they actively remodel the extracellular matrix (ECM) to create a stiff, cross‑linked niche that mechanically suppresses proliferation of neighboring stem and progenitor cells. This mechanochemical signal works in concert with the SASP to enforce a "hostage‑negotiator" state: the matrix transmits contractile forces that inhibit YAP/TAZ nuclear translocation, keeping progenitors quiescent. Chronic senescent cells sustain this loop through persistent NF‑κB/STAT3‑driven up‑regulation of lysyl oxidase (LOX) and LOXL2, which crosslink collagen and fibronectin. When senolytics remove these cells abruptly, the ECM remains over‑crosslinked for a short window, causing a transient surge in matrix stiffness that hyperactivates YAP/TAZ in progenitors, driving aberrant proliferation, faulty differentiation, and fibrosis rather than regeneration.

Mechanistic Rationale

• Senescent‑cell‑derived LOX – Senescent fibroblasts increase LOX expression via NF‑κB signaling (see SASP shift in chronic senescence) 6. LOX catalyzes oxidative deamination of lysine residues, forming aldehydes that condense into collagen cross‑links, raising tissue elastic modulus.
• ECM‑stiffness‑YAP/TAZ axis – Elevated stiffness promotes integrin‑FAK signaling, leading to LATS1/2 inhibition and YAP/TAZ nuclear entry, which drives transcription of proliferation genes (CTGF, CYR61) and pro‑fibrotic mediators (CTGF, TGF‑β1).
• Feedback to SASP – Nuclear YAP/TAZ can amplify NF‑κB activit

Hypothesis

Chronic elevation of mitochondrial DNA heteroplasmy triggers a sustained retrograde signal that reprograms nuclear epigenetic landscapes, establishing a self‑reinforcing "epigenetic lock" that drives cellular senescence independent of nuclear DNA damage.

Mechanistic Model

1. Persistent ROS and altered NAD+/NADH ratios from mutant mtDNA OXPHOS deficiency activate stress‑sensing kinases (AMPK, SIRT1/3) and inhibit sirtuin deacetylase activity.
2. Reduced SIRT1/3 activity leads to hyperacetylation of nuclear histones and transcription factors, shifting gene expression toward a pro‑senescent SASP profile.
3. Acetyl‑CoA surplus (from impaired TCA flux) fuels histone acetyltransferases, locking chromatin in an open, transcriptionally active state at senescence‑associated loci.
4. Mitonuclear communication via mtDNA‑derived peptides (e.g., humanin) and mitochondrial nucleic acids (mtDNA fragments, mtRNA) engages cytosolic pattern‑recognition receptors (cGAS‑STING, TLR9), reinforcing NF‑κB driven inflammation.
5. This loop is self‑propagating: SASP factors further impair mitochondrial biogenesis via p53‑PGC‑1α axis suppression, maintaining high heteroplasmy and epigenetic dysregulation.

Testable Predictions

• Prediction 1: Reducing heteroplasmy below a tissue‑specific threshold (≈30 % mutant load) will normalize nuclear histone acetylation levels and delay epigenetic aging clocks, even when nuclear DNA damage remains unchanged.
• Prediction 2: Pharmacological restoration of SIRT1 activity (e.g., with NAD+ precursors) will break t

Background Recent work highlights that gut-derived signals set the brain’s homeostatic baseline, yet the complementary efferent arm—brain‑to‑gut communication—remains untested in aging contexts 1. The vagus nerve provides cholinergic input to the intestinal crypts, and muscarinic receptor activation can modulate the ERK1/2 import machinery that controls nuclear translocation of phosphorylated ERK 2. Age‑related loss of orexin‑producing neurons in the lateral hypothalamus reduces vagal efferent firing, a change documented in multiple models of frailty 3.

Mechanistic basis We propose that diminished orexin‑driven vagal tone lowers acetylcholine release in the gut, leading to decreased signaling through M3 muscarinic receptors on intestinal stem cells (ISCs). M3 coupling to Gq/11 activates phospholipase Cβ, producing IP3 and DAG, which stimulate PKC‑dependent pathways that promote ERK1/2 nuclear import complex activity (e.g., importin‑7 phosphorylation). When this pathway is weak, p‑ERK1/2 accumulates in the cytoplasm, sustaining transcription of p21 and SASP factors and driving ISC senescence 2. Conversely, robust vagal‑orexin signaling promotes ERK nuclear entry, allowing transient ERK activity to support proliferation without triggering the senescence program.

Testable predictions

1. Aged mice with chemogenetic inhibition of lateral hypothalamus orexin neurons will show re

Hypothesis

Chronic brain‑derived neuropeptide Y (NPY) signaling via vagal efferents suppresses intestinal epithelial mTORC1 activity, thereby enhancing autophagy and reshaping the gut microbiota to promote systemic longevity.

Mechanistic Rationale

et al. note that most longevity work treats the gut→brain axis as the dominant causal direction, yet brain‑to‑gut signaling remains mechanistically underexplored [1]. NPY is a well‑characterized hypothalamic peptide released during stress and energy‑balance regulation, and vagal efferents convey NPY to the gut wall [2]. In intestinal epithelial cells, NPY binds Y1 receptors that inhibit mTORC1 through upstream activation of TSC2, a pathway shown to stimulate autophagy in multiple tissues [3]. Enhanced autophagy in gut epithelium can improve barrier integrity, reduce inflammaging, and alter mucosal niches that favor beneficial microbial taxa [4]. Conversely, impaired gut autophagy drives dysbiosis and systemic inflammation, accelerating aging phenotypes [5]. Thus, brain NPY may set a basal autophagic tone in the gut that overrides cell‑autonomous aging cues.

Testable Predictions

1. Elevating central NPY (via hypothalamic overexpression or pharmacological agonism) will increase LC3‑II/I ratios and p62 degradation specifically in intestinal epithelial cells of aged mice.
2. Vagotomy will abolish the NPY‑induced autophagy boost in the gut, confirming efferent dependence.
3. Mice with sustained central NPY elevation will exhibit a shift toward higher relative abundance of butyrate‑producing taxa (e.g., Faecalibaculum spp.

Background

Autoantibody epitope spreading — the progressive diversification of autoantibody specificities targeting new epitopes on the same or different autoantigens — is a hallmark of systemic lupus erythematosus (SLE) progression. Clinically, epitope spreading often precedes organ involvement expansion (e.g., anti-dsDNA → anti-C1q → renal flare). However, current serological monitoring detects new specificities only after B-cell maturation and antibody secretion have already occurred, missing the upstream germinal center (GC) dysregulation window.

Circulating follicular helper T cells (cTfh, CXCR5+PD-1+CD4+) provide critical help to B cells within GCs, while follicular regulatory T cells (Tfr, CXCR5+Foxp3+CD4+) suppress excessive GC reactions. The Tfr/Tfh ratio reflects the balance between GC promotion and restraint. Concurrently, serum CXCL13 — a B-cell chemoattractant produced primarily within GCs — serves as a peripheral surrogate of GC activity.

Hypothesis

We hypothesize that serial measurement of the circulating Tfr/Tfh ratio combined with serum CXCL13 trajectory slope will predict autoantibody epitope spreading events in SLE 8–18 weeks before new autoantibody specificities become detectable by conventional immunoassay. Specifically:

1. A sustained decline in the Tfr/Tfh ratio below a patient-specific baseline (>1.5 SD reduction over ≥3 consecutive measurements) indicates loss of GC regulatory control.
2. A concurrent CXCL13 trajectory slope exceeding 15 pg/mL/month reflects accelerating GC activity.
3. The conjunction of both signals (Tfr/Tfh decline + C

Hypothesis

Chronic low‑grade translocation of gut‑derived lipopolysaccharide (LPS) activates endothelial Toll‑like receptor 4 (TLR4), which uncouples endothelial nitric oxide synthase (eNOS) by increasing NADPH oxidase‑derived reactive oxygen species (ROS) and depleting tetrahydrobiopterin (BH4). This mechanism reduces nitric oxide (NO) bioavailability, elevates asymmetric dimethylarginine (ADMA)‑mediated eNOS inhibition, and accelerates arterial stiffening as measured by pulse wave velocity (PWV). Consequently, increased PWV exacerbates perfusion‑dependent nerve fiber damage in the brain, raising neurofilament light chain (NfL) levels and precipitating early memory decline. Restoring gut barrier integrity or blocking endothelial TLR4 will normalize eNOS coupling, improve NO-mediated vasodilation, lower PWV, and attenuate NfL rise, thereby preserving cognitive function independent of traditional cardiovascular risk factors.

Mechanistic Rationale

1. LPS‑TLR4 signaling in endothelium – LPS binds TLR4 on endothelial cells, triggering MyD88‑dependent NF‑κB activation and up‑regulating NOX2/NOX4 NADPH oxidase isoforms. The resulting superoxide (O₂⁻) reacts with NO to form peroxynitrite, further oxidizing BH4 to BH2, promoting eNOS uncoupling (producing O₂⁻ instead of NO) [2].
2. BH4 depletion and ADMA rise – Uncoupled eNOS exacerbates oxidative stress, which stimulates arginase I and dimethylarginine dimethylaminohydrolase (DDAH) inhibition, lowering L‑arginine availability and increasing ADMA, a competi

Hypothesis

With advancing age, enterochromaffin (EC) cells accumulate mitochondrial-derived reactive oxygen species (ROS) that selectively oxidize cysteine residues in the pore region of Piezo2 mechanosensitive channels. This oxidative modification lowers Piezo2 open probability, blunting the Ca2+ influx needed for action potential‑dependent serotonin (5‑HT) release. Consequently, mechanosensitive 5‑HT output falls despite unchanged EC cell number or TPH1 expression, contributing to slowed colonic transit and the shift toward a pro‑inflammatory microbiome observed in aged individuals.

Mechanistic Rationale

1. EC cells are redox‑sensitive – They express NADPH oxidases and mitochondrial complexes that generate ROS in response to microbial metabolites [1]. Aging is known to increase mitochondrial ROS production in many intestinal epithelial cell types, leading to oxidative stress‑induced protein modifications.
2. Piezo2 activity depends on cysteine redox state – Structural studies show that several extracellular cysteines regulate channel gating; oxidation can stabilize the closed conformation [2]. No study has yet examined whether EC‑cell Piezo2 is similarly regulated.
3. Mechanosensitive 5‑HT release drives motility and microbiome homeostasis – Piezo2‑dependent Ca2+ spikes trigger vesicle fusion and 5‑HT excretion, which stimulates peristalsis and shapes bacterial communities via immune modulation [3]. A decline in this signal would reduce fluid secretion and favor anaerobic, mucin‑degrading taxa that thrive in slower transit.
4. **TPH1 expression may